Welcome to
The Psychosis Metabolic Risk Calculator
An innovative tool enabling early intervention and prevention of cardiometabolic morbidity in early psychosis.
Benjamin I. Perry
Emanuele F. Osimo
Shuqing Si
Clara Lewis
Ben Laws
Karla Hitchins
Claire Friedrich
Roshni Bahri
James Hotham
Joie Ensor
Graham M. Murray
Simon J. Griffin
Golam M. Khandaker
David Shiers OBE
Richard I.G. Holt
Peter B. Jones
Xiaoxuan Liu
Alastair K. Denniston
Annabel Walsh
McPin Foundation
Shizana Arshad
Centre for Mental Health
Nathalia Garrido-Torres
Benedicto Crespo-Facorro
Frederik Vandenberghe
Chin B. Eap
Jaakko Keinänen
Saana Eskelinen
Version:
Manufacturer:
University of Birmingham Enterprise Limited
University of Birmingham, Edgbaston, Birmingham, B15 2TT
Date of Last Update:
Instructions:
Consult this page and the embedded help pages for correct use.
Warning:
PsyMetRiC is designed to inform clinical decisions but must not drive them. Clinical decisions should rely on a range of information including patient preference.
Performance of PsyMetRiC is reliant upon an internet connection.
Intended Use:
PsyMetRiC is a web-based clinical decision support tool intended for use by qualified health professionals caring for young adults aged 16–35 who are receiving assessment or treatment for early psychosis. It calculates and displays estimates of the likelihood of developing short, medium and longer-term cardiometabolic outcomes. For selected outcomes, it also displays modelled estimates of how risk might change under specified prevention scenarios.
Classification: Class I Medical Device under UK MDR 2002
Serious Incident Reporting:
If a user experiences a serious incident, this should be reported to the developers through either the feedback form on this app, at [email protected], or to the MHRA.